《Table 3Characteristics of tumor and patients in the different risk groups.》

  提示：宽带有限、当前游客访问压缩模式

本系列图表出处文件名：随高清版一同展现

《Novel biomarkers GEP/ABCB5 regulate response to adjuvant transarterial chemoembolization after curative hepatectomy for hepatocellular carcinoma》

1. 获取 高清版本忘记账户？点击这里登录

1. 下载图表忘记账户？点击这里登录

AFP:alpha-fetoprotein；AJCC:American Joint Committee on Cancer.

Patients were segregated according to their GEP/ABCB5 status and the response to adjuvant TACE was analyzed.Characteristics of tumor and patients in difference risk groups were demonstrated in Table 3.Patients in different risk groups had significantly different overall survival（P=0.044）（Fig.2 E） .Patients in the low risk group enjoyed the best overall survival while patients in the high risk group had the worst overall survival.The early recurrence rate of low，intermediate and high risk groups were 20.0%，33.3%and50.0%，respectively（P=0.248）.The 2-year disease-free survival of low，intermediate and high risk group were 80.0%，60.0%and 50.0%，respectively（P=0.435）（Fig.2 F） .